Additionally, the analog of ATR, Carboxy-ATR, can also improve the degree of obesity and hepatic steatosis in mice (Cho et al., 2017) by inhibiting ANT in a noncompetitive manner (Stewart and Steenkamp, 2000). This evidence concerns the gene ATR and fatty liver disease.